These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26173670)

  • 21. Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases.
    Corrao G; Zambon A; Bertù L; Botteri E; Leoni O; Contiero P
    J Epidemiol Community Health; 2004 Dec; 58(12):1047-51. PubMed ID: 15547071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memory loss from statins unlikely.
    Harv Heart Lett; 2014 Mar; 24(7):8. PubMed ID: 24868612
    [No Abstract]   [Full Text] [Related]  

  • 23. Do statin drugs impair memory?
    Harv Mens Health Watch; 2012 Sep; 17(2):7. PubMed ID: 23050284
    [No Abstract]   [Full Text] [Related]  

  • 24. Rhabdomyolysis and lipid-lowering drugs.
    Tenenbaum A; Fisman EZ; Motro M
    JAMA; 2005 Mar; 293(12):1448; author reply 1448-9. PubMed ID: 15784863
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensive LDL-cholesterol lowering therapy and neurocognitive function.
    Banach M; Rizzo M; Nikolic D; Howard G; Howard V; Mikhailidis D
    Pharmacol Ther; 2017 Feb; 170():181-191. PubMed ID: 27865998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How well tolerated are lipid-lowering drugs?
    Tomlinson B; Chan P; Lan W
    Drugs Aging; 2001; 18(9):665-83. PubMed ID: 11599634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stroke prevention by statins].
    Sawada N; Itoh H; Nakao K
    Nihon Rinsho; 2002 May; 60(5):993-1001. PubMed ID: 12030004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.
    Hanna IR; Heeke B; Bush H; Brosius L; King-Hageman D; Dudley SC; Beshai JF; Langberg JJ
    Heart Rhythm; 2006 Aug; 3(8):881-6. PubMed ID: 16876733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New evidence for beneficial effects of statins unrelated to lipid lowering.
    Palinski W
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):3-5. PubMed ID: 11145927
    [No Abstract]   [Full Text] [Related]  

  • 30. Statins differ significantly in their anti-inflammatory activity.
    Kwatra SG
    J Am Acad Dermatol; 2011 Dec; 65(6):1229; author reply 1229-30. PubMed ID: 22082842
    [No Abstract]   [Full Text] [Related]  

  • 31. Statin use and risk of first-time psoriasis diagnosis.
    Brauchli YB; Jick SS; Meier CR
    J Am Acad Dermatol; 2011 Jul; 65(1):77-83. PubMed ID: 21529997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current and future options for lipid-lowering therapy beyond statins.
    Gouni-Berthold I
    Curr Pharm Des; 2013; 19(17):3072-3. PubMed ID: 23317406
    [No Abstract]   [Full Text] [Related]  

  • 33. High-dose statins in acute coronary syndromes: not just lipid levels.
    Nissen SE
    JAMA; 2004 Sep; 292(11):1365-7. PubMed ID: 15337731
    [No Abstract]   [Full Text] [Related]  

  • 34. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 35. [Statins in lowering cholesterol in the elderly].
    Guo YF; Hu DY
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):893-4. PubMed ID: 18261267
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipid-lowering agents that cause drug-induced hepatotoxicity.
    Bhardwaj SS; Chalasani N
    Clin Liver Dis; 2007 Aug; 11(3):597-613, vii. PubMed ID: 17723922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ezetimibe: caution in the face of doubt].
    Araujo F; Mateo de Castro J; Encinas Barrios C
    Farm Hosp; 2010; 34(4):212-4. PubMed ID: 20153227
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid-lowering agents and risk of melanoma.
    Kirsner RS; Ramirez CC; Federman DG; Ma F
    Int J Cancer; 2005 Nov; 117(2):333; author reply 334. PubMed ID: 15900582
    [No Abstract]   [Full Text] [Related]  

  • 39. Fenofibrate profiled as the fibrate with additional new data, supporting its use with statins in the European Medicines Agency recommendations.
    Cardiovasc J Afr; 2011; 22(1):55. PubMed ID: 21298212
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kidney and statins].
    Moulin B; Caillard S
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 2):121-7. PubMed ID: 11240414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.